Pearl Bio
Stamford, US · Founded 2020 · Delaware corporation · 10 employees on LinkedIn · 1 known investors
Find your way into Pearl Bio
401 people in our graph share verified history with the Pearl Bio team — schools, employers, funds. One of them is your warm intro.
Ben Lererunlockedknows Amy Cayne Schwartz · together at University of Pennsylvania (overlapped)
%20(1).webp)
×2knows the team · via The London School of Economics and Political Science (LSE)
×3knows the team · via Massachusetts Institute of Technology
×2knows the team · via University of Pennsylvania
×4knows the team · via Fordham University School of Law
Pearl Bio develops technologies for genome engineering, ribosome engineering, and biomanufacturing to enable production of novel proteins, chemicals, and materials for biotechnology and medicine.
Founders & leadership
Pearl Bio was founded in 2020 by Farren Isaacs, Michael Jewett, and Amy Cayne Schwartz.
FI
Farren IsaacsCo-Founder and Science Advisor
MJ
Michael JewettinCo-Founder and Science Advisor
AC
Amy Cayne SchwartzinCo-Founder, COO & CBOAmy Cayne Schwartz practiced corporate law at major Wall Street firms serving Fortune 500 clients, led Genome Project-write as President and General Counsel overseeing legal matters and technical working groups, and holds a B.A. from the University of Pennsylvania, a J.D. from Fordham School of Law, and a certification in biomanufacturing from MIT; she co-founded Pearl Bio where she serves as COO, CBO & General Counsel.
MG
Merton GollaherExecutive
Board
GC
George ChurchScience Advisor
JR
Jesse RinehartScience Advisor
Investors · 1
Reported raises · per SEC filings
Form D private placements$4.1M disclosed across 1 round · 2021
▶$4.1MraisedOct 2021 · 3 investors · BiotechnologyRule 506(b)
▶$4.1MraisedOct 2021 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Merton GollaherExecutive Officer
- Farren IsaacsExecutive Officer, Director
- Michael JewettExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $4.1M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapPillar Biosciences9 shared keywordsPillar Biosciences develops kitted next-generation sequencing (NGS) panels and its SLIMamp single-tube library preparation technology for clinical and research laboratories, focused on cancer diagnostics. Its oncoReveal portfolio of RUO and IVD oncology panels covers solid tumors, hematologic cancers, and liquid biopsy, aiming to deliver faster, lower-cost genomic testing for precision medicine.
Pattern5 shared keywordsPattern develops rapid antibiotic susceptibility and infection diagnostics using single-cell microbiology, which reads the metabolic patterns of individual bacterial cells to deliver ID/AST results in hours without culture steps. Its phenotypic testing targets common infection sites to support faster, more focused antibiotic treatment in hospitals and combat antibiotic resistance.
Pear Bio5 shared keywordsPear Bio delivers precision medicine tests and therapeutics for patients with hard-to-treat cancers by creating personalized treatment predictions from tumor biopsies and developing novel targeted therapies.
Parallel Bio5 shared keywordsParallel Bio develops human immune organoids and computational tools to predict drug efficacy across diverse patient populations, replacing animal testing in drug discovery. The company aims to accelerate pharmaceutical development and reduce clinical trial failure rates through human-first biological prediction models.
Companies competing with Pearl Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2023 | $274.5K |
| Department of DefenseOffice of the Secretary of Defense | Phase ISTTR | 2023 | $250K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Pearl Bio do?
- Pearl Bio develops technologies for genome engineering, ribosome engineering, and biomanufacturing to enable production of novel proteins, chemicals, and materials for biotechnology and medicine.
- Who founded Pearl Bio?
- Pearl Bio was founded by Farren Isaacs, Michael Jewett, Amy Cayne Schwartz in 2020.
- Who are Pearl Bio's investors?
- Pearl Bio's investors include Khosla Ventures.
- How much funding has Pearl Bio raised?
- Pearl Bio has disclosed $4.1M raised across 1 round.
- Where is Pearl Bio headquartered?
- Pearl Bio is headquartered in Stamford, US.